Jana Harris is a registered patent attorney and focuses her patent practice on technologies in the life sciences industry. She represents start-ups, universities, and life science companies with technologies relating to oncology, immuno-oncology, gene-editing, biomarkers, diagnostics, biologics, stem cell compositions, proteomics, genetics, food and agriculture science, drug delivery and medical devices.
Jana builds global intellectual property portfolios through strategic procurement, management, and defense to help optimize patent and regulatory exclusivity and lifecycle management for pre-clinical and post-clinical products and technologies. She renders legal opinions and risk-assessment with respect to inventorship, patentability, validity, and freedom-to-operate to assist in business decisions. She also negotiates, drafts, and performs due diligence relating to licenses, mergers and acquisitions, and other intellectual property related agreements. Her legal practice further encompasses brand development, trademark prosecution and clearance, enforcement and defense strategy consulting, litigation, and transactions. She has experience representing clients in patent and trademark infringement, ITC, DMCA, UDRP, and opposition/cancellation proceedings.
Prior to practicing law, Jana obtained her Ph.D. in Cell and Developmental Biology from Vanderbilt University and was a postdoctoral fellow in the Department of Anesthesiology. While at Vanderbilt, she discovered and characterized a novel cytoskeletal rearrangement in C. elegans oocytes in response to hormonal signaling during fertilization. Her research resulted in a first author paper in Developmental Biology and she was awarded the cover photo of the journal.
- Global intellectual property portfolio procurement and management
- Technology transactions and licensing
- Intellectual property enforcement and defense strategic counseling
- Global brand development